MYD88 and hepatocellular carcinoma: In particular, HBX activates the downstream signaling molecules of MyD88, including IRAK1, ERK/p38, and NF-κB, to induce the production of IL-6, a major inflammatory cytokine that facilitates the development of HCC (67).